238 related articles for article (PubMed ID: 22971785)
1. Molecular pathogenesis of myocardial remodeling and new potential therapeutic targets in chronic heart failure.
Distefano G; Sciacca P
Ital J Pediatr; 2012 Sep; 38():41. PubMed ID: 22971785
[TBL] [Abstract][Full Text] [Related]
2. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes.
Wohlschlaeger J; Schmitz KJ; Schmid C; Schmid KW; Keul P; Takeda A; Weis S; Levkau B; Baba HA
Cardiovasc Res; 2005 Dec; 68(3):376-86. PubMed ID: 16024006
[TBL] [Abstract][Full Text] [Related]
3. A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling.
Schirone L; Forte M; Palmerio S; Yee D; Nocella C; Angelini F; Pagano F; Schiavon S; Bordin A; Carrizzo A; Vecchione C; Valenti V; Chimenti I; De Falco E; Sciarretta S; Frati G
Oxid Med Cell Longev; 2017; 2017():3920195. PubMed ID: 28751931
[TBL] [Abstract][Full Text] [Related]
4. Combined therapy with cardioprotective cytokine administration and antiapoptotic gene transfer in postinfarction heart failure.
Okada H; Takemura G; Kosai K; Tsujimoto A; Esaki M; Takahashi T; Nagano S; Kanamori H; Miyata S; Li Y; Ohno T; Maruyama R; Ogino A; Li L; Nakagawa M; Nagashima K; Fujiwara T; Fujiwara H; Minatoguchi S
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H616-26. PubMed ID: 19151252
[TBL] [Abstract][Full Text] [Related]
5. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
[TBL] [Abstract][Full Text] [Related]
6. [Molecular and cellular mechanisms of myocardial remodeling in heart failure].
Kremneva LV; Abaturova OV
Klin Med (Mosk); 2003; 81(2):4-7. PubMed ID: 12685226
[TBL] [Abstract][Full Text] [Related]
7. Molecular and cellular mechanisms of myocardial failure.
Colucci WS
Am J Cardiol; 1997 Dec; 80(11A):15L-25L. PubMed ID: 9412539
[TBL] [Abstract][Full Text] [Related]
8. The fibrosis-cell death axis in heart failure.
Piek A; de Boer RA; Silljé HH
Heart Fail Rev; 2016 Mar; 21(2):199-211. PubMed ID: 26883434
[TBL] [Abstract][Full Text] [Related]
9. A look between the cardiomyocytes: the extracellular matrix in heart failure.
Miner EC; Miller WL
Mayo Clin Proc; 2006 Jan; 81(1):71-6. PubMed ID: 16438481
[TBL] [Abstract][Full Text] [Related]
10. ST2 silencing aggravates ventricular remodeling and chronic heart failure in rats by mediating the IL-33/ST2 axis.
Zhao YN; Li H; Zhao C; Liu GH
J Tissue Eng Regen Med; 2020 Sep; 14(9):1201-1212. PubMed ID: 32592632
[TBL] [Abstract][Full Text] [Related]
11. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
[TBL] [Abstract][Full Text] [Related]
12. [PTEN/PI3K pathways are involved in the signal transduction of myocardial remodeling in patients with congestive heart failure].
Yang YJ; Zhu WL; Zhang X; Zhou XW; Zhu ZM
Zhonghua Yi Xue Za Zhi; 2005 May; 85(17):1201-4. PubMed ID: 16029597
[TBL] [Abstract][Full Text] [Related]
13. [Apoptosis of cardiomyocytes, cytokines and remodeling of myocardium against the development of chronic heart failure].
Dynnik OB; Gavrilenko TI; Zalesskiĭ VN
Lik Sprava; 2005; (5-6):3-10. PubMed ID: 16396282
[TBL] [Abstract][Full Text] [Related]
14. Thrombospondins in the transition from myocardial infarction to heart failure.
Kirk JA; Cingolani OH
J Mol Cell Cardiol; 2016 Jan; 90():102-10. PubMed ID: 26686988
[TBL] [Abstract][Full Text] [Related]
15. Reversibility of adverse, calcineurin-dependent cardiac remodeling.
Berry JM; Le V; Rotter D; Battiprolu PK; Grinsfelder B; Tannous P; Burchfield JS; Czubryt M; Backs J; Olson EN; Rothermel BA; Hill JA
Circ Res; 2011 Aug; 109(4):407-17. PubMed ID: 21700928
[TBL] [Abstract][Full Text] [Related]
16. Cardiac regeneration in 2017: Novel paradigms in the fight against heart failure.
Fernández-Avilés F
Nat Rev Cardiol; 2018 Jan; 15(2):73-74. PubMed ID: 29336435
[No Abstract] [Full Text] [Related]
17. The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.
Frangogiannis NG
Circ Res; 2019 Jun; 125(1):117-146. PubMed ID: 31219741
[TBL] [Abstract][Full Text] [Related]
18. Cardiac fibrosis in the ageing heart: Contributors and mechanisms.
Lu L; Guo J; Hua Y; Huang K; Magaye R; Cornell J; Kelly DJ; Reid C; Liew D; Zhou Y; Chen A; Xiao W; Fu Q; Wang BH
Clin Exp Pharmacol Physiol; 2017 Dec; 44 Suppl 1():55-63. PubMed ID: 28316086
[TBL] [Abstract][Full Text] [Related]
19. Matrix modulation and heart failure: new concepts question old beliefs.
Deschamps AM; Spinale FG
Curr Opin Cardiol; 2005 May; 20(3):211-6. PubMed ID: 15861009
[TBL] [Abstract][Full Text] [Related]
20. Deletion of Microfibrillar-Associated Protein 4 Attenuates Left Ventricular Remodeling and Dysfunction in Heart Failure.
Wang HB; Yang J; Shuai W; Yang J; Liu LB; Xu M; Tang QZ
J Am Heart Assoc; 2020 Sep; 9(17):e015307. PubMed ID: 32856514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
